Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Hodge Carl Nicholas"'
Autor:
Paul Krenitsky, Strucely P, Robert Scott Cheeseman, Hodge Carl Nicholas, Thomas E. Christos, Zelda R. Wasserman, Paul J. Gilligan, Ciganek E, Nemeth Ga, Fernandez Ch, Everett Latham Scholfield, Argyrios G. Arvanitis, Aldrich Pe, Robert J. Chorvat
Publikováno v:
Journal of Medicinal Chemistry. 42:819-832
As described in the preceding paper (Arvanitis et al. J. Med. Chem. 1999, 42), anilinopyrimidines I were identified as potent antagonists of corticotropin-releasing hormone-1 receptor (CRH1-R, also referred to as corticotropin-releasing factor, CRF1-
Autor:
M.C. Schadt, Charles J. Eyermann, Patricia C. Weber, E. E. Huston, Hodge Carl Nicholas, F.A. Lewandowski, D. D. Mccabe, J. L. Duke, R. J. Deloskey, C.-H. Chang, Prabhakar K. Jadhav, Patrick Y.S. Lam, Paul J. Ala
Publikováno v:
Journal of Biological Chemistry. 273:12325-12331
As long as the threat of human immunodeficiency virus (HIV) protease drug resistance still exists, there will be a need for more potent antiretroviral agents. We have therefore determined the crystal structures of HIV-1 protease in complex with six c
Autor:
Charles J. Eyermann, Lee T. Bacheler, Francis J. Woerner, W. F. Daneker, C.-H. Chang, Susan Erickson-Viitanen, Patrick Y.S. Lam, J. L. Meek, M. M. Rayner, M.C. Schadt, H.-W. Man, David A. Jackson, Hodge Carl Nicholas, Joseph C. Calabrese, Prabhakar K. Jadhav
Publikováno v:
Journal of Medicinal Chemistry. 41:1446-1455
Comparison of the high-resolution X-ray structures of the native HIV-1 protease and its complexes with the inhibitors suggested that the enzyme flaps are flexible. The movement at the tip of the flaps could be as large as 7 A. On the basis of this ob
Autor:
Hodge Carl Nicholas, Susan Erickson-Viitanen, Y. N. Wong, M. M. Rayner, M. J. Otto, Fernandez Ch, Aldrich Pe
Publikováno v:
Antiviral Chemistry and Chemotherapy. 5:257-262
Low-molecular-weight peptidyl aldehyde inhibitors of HIV protease that reach in vivo plasma concentrations after oral administration substantiailly in excess of the antiviral IC90 are described. We also report efforts to improve the potency and stabi
Autor:
Dean L. Winslow, Sena Garber, Caroline Reid, Y. S. E. Cheng, Hodge Carl Nicholas, C. E. Patterson, P. E. Aldrich, Prabhakar K. Jadhav, M. J. Otto
Publikováno v:
Proceedings of the National Academy of Sciences. 90:7543-7547
Protease inhibitors are another class of compounds for treatment of human immunodeficiency virus (HIV)-caused disease. The emergence of resistance to the current anti-HIV drugs makes the determination of potential resistance to protease inhibitors im
Autor:
Michael K. Gilson, Joanna Trylska, Martha S. Head, Ronald M. Klabe, Jan M. Antosiewicz, Hodge Carl Nicholas, Maciej Geller
Publikováno v:
Protein science : a publication of the Protein Society. 8(1)
The aspartyl dyad of free HIV-1 protease has apparent pK(a)s of approximately 3 and approximately 6, but recent NMR studies indicate that the aspartyl dyad is fixed in the doubly protonated form over a wide pH range when cyclic urea inhibitors are bo
Autor:
D. D. Mccabe, E. E. Huston, R. J. Deloskey, Ronald M. Klabe, Patrick Y.S. Lam, Hodge Carl Nicholas, C.-H. Chang, C. J. Rizzo, B. D. Korant, Paul J. Ala, J. L. Duke
Publikováno v:
Biochemistry. 36(7)
In cell cultures, the key residues associated with HIV-1 resistance to cyclic urea-based HIV-1 protease (PR) inhibitors are Val82 and Ile84 of HIV-1 PR. To gain an understanding of how these two residues modulate inhibitor binding, we have measured t
Autor:
Y. Ru, G. Emmett, Qi Han, Edward R. Holler, T. R. Sharpe, M. M. Rayner, Hodge Carl Nicholas, Renhua Li, Dean L. Winslow, Robert J. McHugh, P. E. Aldrich, George Vincent Delucca, P. N. Confalone, Jay A. Markwalder, Prabhakar K. Jadhav, L. Li, Steven P. Seitz, C.-H. Chang, Susan Erickson-Viitanen, Charles J. Eyermann, Patrick Y.S. Lam, D. M. Kornhauser, L. Shum, Lee T. Bacheler, David A. Jackson, W. F. Daneker, Ronald M. Klabe
Publikováno v:
Journal of medicinal chemistry. 39(18)
High-resolution X-ray structures of the complexes of HIV-1 protease (HIV-1PR) with peptidomimetic inhibitors reveal the presence of a structural water molecule which is hydrogen bonded to both the mobile flaps of the enzyme and the two carbonyls flan
Autor:
Hodge Carl Nicholas, M. J. Otto, Sena Garber, Dean L. Winslow, Grubb M, L. Shum, Korant B, Patrick Y.S. Lam, J. L. Meek, P. E. Aldrich, Charles J. Eyermann, Lee T. Bacheler, M. M. Rayner, T. R. Sharpe, Prabhakar K. Jadhav, C.-H. Chang, Susan Erickson-Viitanen, Carol Reid, David A. Jackson, Maurin Mb
Publikováno v:
Chemistry & Biology. (4):301-314
Background: Effective HIV protease inhibitors must combine potency towards wild-type and mutant variants of HIV with oral bioavailability such that drug levels in relevant tissues continuously exceed that required for inhibition of virus replication.